155 (40.6%) genetic variants were found in other 35 cancer-associated genes of variable penetrance: 12 (3.1%) variants in high-penetrance genes (CDH1, MLH1, MSH2, TP53) and 143 (37.5%) genetic alterations in the genes with mild to low penetrance. This evidence concerns the gene TP53 and cancer.